Tobira Therapeutics, Inc., formerly Regado BioSciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular indications. As of December 31, 2014, the operations of Regado had been terminated and as such the required business controls have been reduced. The Company has a subsidiary, Regado Biosciences Europe Limited. As of December 31, 2014, Regado Biosciences Europe Limited had no operations.